Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nandita Joshi Jones"'
Autor:
Robert L. Findling, Azmi Nasser, Gregory D. Busse, Nicholas Fry, Nandita Joshi Jones, Tesfaye Liranso, Joseph T. Hull, Fatima Chowdhry, Andrew J. Cutler, Toyin Adewole, Stefan Schwabe
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Purpose This phase 3 clinical trial evaluated the efficacy and safety of viloxazine extended-release capsules (VLX-ER) as a monotherapy for attention-deficit/hyperactivity disorder (ADHD) in
Purpose This phase 3 clinical trial evaluated the efficacy and safety of viloxazine extended-release capsules (VLX-ER) as a monotherapy for attention-deficit/hyperactivity disorder (ADHD) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cef5f15b26f8894ce420a97cff7429
https://doi.org/10.1097/jcp.0000000000001404
https://doi.org/10.1097/jcp.0000000000001404
Autor:
Nicholas Fry, Stefan Schwabe, Andrew J. Cutler, Fatima Chowdhry, Gregory D. Busse, Robert L. Findling, Joseph T. Hull, Azmi Nasser, Nandita Joshi Jones, Tesfaye Liranso, Toyin Adewole
Publikováno v:
Clinical therapeutics. 42(8)
The limitations of current US Food and Drug Administration (FDA)-approved medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) set the need for the development of novel, effective, and tolerable medications to treat this d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3907ff5548d265c3f49fc6b430721fe3
https://pubmed.ncbi.nlm.nih.gov/32723670
https://pubmed.ncbi.nlm.nih.gov/32723670